Skip to main content
Top
Published in: Rheumatology International 9/2017

01-09-2017 | Validation Studies

Reliability and validity of the 12-item WHODAS 2.0 in patients with Kashin–Beck disease

Authors: Mohammad Imran Younus, Di-Miao Wang, Fang-fang Yu, Hua Fang, Xiong Guo

Published in: Rheumatology International | Issue 9/2017

Login to get access

Abstract

The purpose of this study was to check the reliability and validity of the 12-item Chinese version of the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) for the assessment of disability in patients with Kashin–Beck disease (KBD). We recruited 219 patients with KBD from the high-risk KBD area in the Shaanxi province, using stratified multistage random sampling. We assessed each patient using the Chinese version of the 12-item WHODAS 2.0 and the Western Ontario and McMaster Universities Index of Osteoarthritis (WOMAC). Statistical evaluations of the instruments consisted of Cronbach’s alpha, intraclass correlation coefficient (ICC), confirmatory factor analysis (CFA), and Pearson’s correlation coefficient. Cronbach’s alpha and ICC for the six domains ranged from 0.704 to 0.906 and 0.690 to 0.852, respectively. A six-factor structure fits the data well (CFI = 0.967, TLI = 0.944, RMSEA = 0.08). Regarding convergent validity, the four domains of the 12-item WHODAS 2.0 (getting around, self-care, life activity, and participation) showed moderate-to-strong correlation for all three domains of the WOMAC (0.428 < |r| < 0.804). Regarding divergent validity, the two domains of the 12-item WHODAS 2.0 (understanding and communication, and getting along with people) showed weak correlation for the three domains of WOMAC (0.182 < |r| < 0.295). The Chinese version of 12-item WHODAS 2.0 questionnaire is a reliable and valid instrument when administered to KBD patients.
Literature
1.
go back to reference Guo X (2001) Diagnostic, clinical and radiological characteristics of Kashin-Beck disease in Shaanxi Province, PR China. Int Orthop 25(3):147–150CrossRef Guo X (2001) Diagnostic, clinical and radiological characteristics of Kashin-Beck disease in Shaanxi Province, PR China. Int Orthop 25(3):147–150CrossRef
2.
go back to reference Wang Y, Yang Z, Gilula LA, Zhu C (1996) Kashin-Beck disease: radiographic appearance in the hands and wrists. Radiology 201(1):265–270CrossRefPubMed Wang Y, Yang Z, Gilula LA, Zhu C (1996) Kashin-Beck disease: radiographic appearance in the hands and wrists. Radiology 201(1):265–270CrossRefPubMed
3.
go back to reference Cao C-x, Zhang Y-g, Wu S-x, Younas MI, Guo X (2013) Association of clinical features of bone and joint lesions between children and parents with Kashin-Beck disease in Northwest China. Clin Rheumatol 32(9):1309–1316. doi:10.1007/s10067-013-2267-6 CrossRefPubMed Cao C-x, Zhang Y-g, Wu S-x, Younas MI, Guo X (2013) Association of clinical features of bone and joint lesions between children and parents with Kashin-Beck disease in Northwest China. Clin Rheumatol 32(9):1309–1316. doi:10.​1007/​s10067-013-2267-6 CrossRefPubMed
4.
go back to reference Farooq U, Xiong G, Irshad R, Yaqoob S (2010) Pattern of joints involvement in Kashin-Beck disease: a local osteochondropathy in China. J Ayub Med Coll Abbottabad Jamc 22(1):97–100PubMed Farooq U, Xiong G, Irshad R, Yaqoob S (2010) Pattern of joints involvement in Kashin-Beck disease: a local osteochondropathy in China. J Ayub Med Coll Abbottabad Jamc 22(1):97–100PubMed
7.
go back to reference Cao J, Li S, Shi Z, Yue Y, Sun J, Chen J, Fu Q, Hughes CE, Caterson B (2008) Articular cartilage metabolism in patients with Kashin-Beck Disease: an endemic osteoarthropathy in China. Osteoarthr Cartil 16(6):680–688CrossRefPubMed Cao J, Li S, Shi Z, Yue Y, Sun J, Chen J, Fu Q, Hughes CE, Caterson B (2008) Articular cartilage metabolism in patients with Kashin-Beck Disease: an endemic osteoarthropathy in China. Osteoarthr Cartil 16(6):680–688CrossRefPubMed
8.
go back to reference Haubruge E, Chasseur C, Debouck C, Begaux F, Suetens C, Mathieu F, Michel V, Gaspar C, Rooze M, Hinsenkamp M (2001) The prevalence of mycotoxins in Kashin-Beck disease. Int Orthop 25(3):159–161CrossRefPubMedPubMedCentral Haubruge E, Chasseur C, Debouck C, Begaux F, Suetens C, Mathieu F, Michel V, Gaspar C, Rooze M, Hinsenkamp M (2001) The prevalence of mycotoxins in Kashin-Beck disease. Int Orthop 25(3):159–161CrossRefPubMedPubMedCentral
9.
go back to reference Chasseur C, Suetens C, Michel V, Mathieu F, Begaux F, Nolard N, Haubruge E (2001) A 4-year study of the mycological aspects of Kashin-Beck disease in Tibet. Int Orthop 25(3):154–158CrossRefPubMedPubMedCentral Chasseur C, Suetens C, Michel V, Mathieu F, Begaux F, Nolard N, Haubruge E (2001) A 4-year study of the mycological aspects of Kashin-Beck disease in Tibet. Int Orthop 25(3):154–158CrossRefPubMedPubMedCentral
10.
go back to reference Yao Y, Pei F, Kang P (2011) Selenium, iodine, and the relation with Kashin-Beck disease. Nutrition 27(11–12):1095–1100CrossRefPubMed Yao Y, Pei F, Kang P (2011) Selenium, iodine, and the relation with Kashin-Beck disease. Nutrition 27(11–12):1095–1100CrossRefPubMed
11.
go back to reference Ge K, Yang G (1993) The epidemiology of selenium deficiency in the etiological study of endemic diseases in China. Am J Clin Nutr 57(2 Suppl):259S–263SPubMed Ge K, Yang G (1993) The epidemiology of selenium deficiency in the etiological study of endemic diseases in China. Am J Clin Nutr 57(2 Suppl):259S–263SPubMed
12.
go back to reference Zhang YZ, Guo XO, Ping ZG, Yu M, Shi XW, Lv A, Wang F, Wang ZW (2009) Main source of drinking water and familial aggregation of Kashin-Beck disease: a population based on case-control family study. Ann Epidemiol 19(8):560–566CrossRefPubMed Zhang YZ, Guo XO, Ping ZG, Yu M, Shi XW, Lv A, Wang F, Wang ZW (2009) Main source of drinking water and familial aggregation of Kashin-Beck disease: a population based on case-control family study. Ann Epidemiol 19(8):560–566CrossRefPubMed
13.
go back to reference Yang C, Niu C, Bodo M, Gabriel E, Notbohm H, Wolf E, Muller PK (1993) Fulvic acid supplementation and selenium deficiency disturb the structural integrity of mouse skeletal tissue. An animal model to study the molecular defects of Kashin-Beck disease. Biochem J 289(Pt 3):829–835 Yang C, Niu C, Bodo M, Gabriel E, Notbohm H, Wolf E, Muller PK (1993) Fulvic acid supplementation and selenium deficiency disturb the structural integrity of mouse skeletal tissue. An animal model to study the molecular defects of Kashin-Beck disease. Biochem J 289(Pt 3):829–835
14.
go back to reference Ustun TB, Chatterji S, Kostanjsek N, Rehm J, Kennedy C, Epping-Jordan J, Saxena S, von Korff M, Pull C (2010) Developing the World Health Organization Disability Assessment Schedule 2.0. Bull World Health Org 88(11):815-823. doi:10.2471/blt.09.067231 Ustun TB, Chatterji S, Kostanjsek N, Rehm J, Kennedy C, Epping-Jordan J, Saxena S, von Korff M, Pull C (2010) Developing the World Health Organization Disability Assessment Schedule 2.0. Bull World Health Org 88(11):815-823. doi:10.​2471/​blt.​09.​067231
15.
go back to reference Rehm J, Üstün TB, Saxena S, Nelson CB, Chatterji S, Ivis F, Adlaf E (1999) On the development and psychometric testing of the WHO screening instrument to assess disability in the general population. Int J Methods Psychiatr Res 8(2):110–122CrossRef Rehm J, Üstün TB, Saxena S, Nelson CB, Chatterji S, Ivis F, Adlaf E (1999) On the development and psychometric testing of the WHO screening instrument to assess disability in the general population. Int J Methods Psychiatr Res 8(2):110–122CrossRef
16.
go back to reference Garin O, Ayuso-Mateos JL, Almansa J, Nieto M, Chatterji S, Vilagut G, Alonso J, Cieza A, Svetskova O, Burger H (2010) Validation of the “World Health Organization Disability Assessment Schedule, WHODAS-2” in patients with chronic diseases. Health Qual Life Outcomes 8(1):1–15CrossRef Garin O, Ayuso-Mateos JL, Almansa J, Nieto M, Chatterji S, Vilagut G, Alonso J, Cieza A, Svetskova O, Burger H (2010) Validation of the “World Health Organization Disability Assessment Schedule, WHODAS-2” in patients with chronic diseases. Health Qual Life Outcomes 8(1):1–15CrossRef
17.
go back to reference Kutlay Ş, Küçükdeveci AA, Elhan AH, Öztuna D, Koç N, Tennant A (2011) Validation of the World Health Organization disability assessment schedule II (WHODAS-II) in patients with osteoarthritis. Rheumatol Int 31(3):339–346. doi:10.1007/s00296-009-1306-8 CrossRefPubMed Kutlay Ş, Küçükdeveci AA, Elhan AH, Öztuna D, Koç N, Tennant A (2011) Validation of the World Health Organization disability assessment schedule II (WHODAS-II) in patients with osteoarthritis. Rheumatol Int 31(3):339–346. doi:10.​1007/​s00296-009-1306-8 CrossRefPubMed
18.
go back to reference Chinese Kashin-Beck Disease Surveillance Group (2003) The monitoring report of Kashin-Beck disease prevalence rate of the whole country in 2003. Chin J Endemiol 23(5):147–149 Chinese Kashin-Beck Disease Surveillance Group (2003) The monitoring report of Kashin-Beck disease prevalence rate of the whole country in 2003. Chin J Endemiol 23(5):147–149
19.
go back to reference Chinese Kashin-Beck Disease Surveillance Group (2006) The monitoring report of Kashin-Beck disease prevalence rate of the whole country in 2006. Chin J Endemiol 25(5):540 Chinese Kashin-Beck Disease Surveillance Group (2006) The monitoring report of Kashin-Beck disease prevalence rate of the whole country in 2006. Chin J Endemiol 25(5):540
21.
go back to reference Mcconnell S, Kolopack P, Davis AM (2001) The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): a review of its utility and measurement properties. Arthr Care Res 45(5):453–461CrossRef Mcconnell S, Kolopack P, Davis AM (2001) The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): a review of its utility and measurement properties. Arthr Care Res 45(5):453–461CrossRef
23.
go back to reference Terwee CB, Bot SD, de Boer MR, Da VDW, Knol DL, Dekker J, Bouter LM, de Vet HC (2007) Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 60(1):34–42CrossRefPubMed Terwee CB, Bot SD, de Boer MR, Da VDW, Knol DL, Dekker J, Bouter LM, de Vet HC (2007) Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 60(1):34–42CrossRefPubMed
24.
go back to reference Cicchetti DV (1994) Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychol Assess 6(4):284–290CrossRef Cicchetti DV (1994) Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychol Assess 6(4):284–290CrossRef
25.
go back to reference Markus KA (2012) Principles and practice of structural equation modeling by rex B. Kline. Struct Eq Model A Multidiscip J 19(3):509–512 Markus KA (2012) Principles and practice of structural equation modeling by rex B. Kline. Struct Eq Model A Multidiscip J 19(3):509–512
27.
go back to reference Campbell DT, Fiske DW (1959) Convergent and discriminant validation by the multitrait-multimethod matrix. Psychol Bull 56(56):81–105CrossRefPubMed Campbell DT, Fiske DW (1959) Convergent and discriminant validation by the multitrait-multimethod matrix. Psychol Bull 56(56):81–105CrossRefPubMed
29.
go back to reference Baron M, Schieir O, Hudson M, Steele R, Kolahi S, Berkson L, Couture F, Fitzcharles MA, Gagne M, Garfield B, Gutkowski A, Kang H, Kapusta M, Ligier S, Mathieu JP, Menard H, Starr M, Stein M, Zummer M (2008) The clinimetric properties of the World Health Organization disability assessment schedule II in early inflammatory arthritis. Arthritis Rheum 59(3):382–390. doi:10.1002/art.23314 CrossRefPubMed Baron M, Schieir O, Hudson M, Steele R, Kolahi S, Berkson L, Couture F, Fitzcharles MA, Gagne M, Garfield B, Gutkowski A, Kang H, Kapusta M, Ligier S, Mathieu JP, Menard H, Starr M, Stein M, Zummer M (2008) The clinimetric properties of the World Health Organization disability assessment schedule II in early inflammatory arthritis. Arthritis Rheum 59(3):382–390. doi:10.​1002/​art.​23314 CrossRefPubMed
30.
go back to reference Moen VP, Drageset J, Eide GE, Klokkerud M, Gjesdal S (2017) Validation of World Health Organization Assessment Schedule 2.0 in specialized somatic rehabilitation services in Norway. Qual Life Res 26(2):505–514. doi:10.1007/s11136-016-1384-5 CrossRefPubMed Moen VP, Drageset J, Eide GE, Klokkerud M, Gjesdal S (2017) Validation of World Health Organization Assessment Schedule 2.0 in specialized somatic rehabilitation services in Norway. Qual Life Res 26(2):505–514. doi:10.​1007/​s11136-016-1384-5 CrossRefPubMed
Metadata
Title
Reliability and validity of the 12-item WHODAS 2.0 in patients with Kashin–Beck disease
Authors
Mohammad Imran Younus
Di-Miao Wang
Fang-fang Yu
Hua Fang
Xiong Guo
Publication date
01-09-2017
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 9/2017
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-017-3723-4

Other articles of this Issue 9/2017

Rheumatology International 9/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.